A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis

Clinical trial NCT00171171 · COMPLETED

Trial details

NCT number: NCT00171171
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Beta-Thalassemia Hemosiderosis

Start date: 2004-05-01
Primary completion: 2006-11-01
Enrollment: 252

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.